RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Robert Holt to Cyclin-Dependent Kinase Inhibitor p16

Back to Details
This is a "connection" page, showing publications Robert Holt has written about Cyclin-Dependent Kinase Inhibitor p16.
Robert Holt
Connection Strength
0.156
Cyclin-Dependent Kinase Inhibitor p16
  1. Sneddon S, Dick I, Lee YCG, Musk AWB, Patch AM, Pearson JV, Waddell N, Allcock RJN, Holt RA, Robinson BWS, Creaney J. Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations. Lung Cancer. 2018 05; 119:64-70.
    View in: PubMed
    Score: 0.156
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support